Literature DB >> 18789919

Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue-interactions with insulin.

Stina M Johansson1, Eva Lindgren, Jiang-Ning Yang, Andreas W Herling, Bertil B Fredholm.   

Abstract

Adenosine acting at adenosine A1 receptors is considered to be one major regulator of adipose tissue physiology. We have examined the role of adenosine and its interactions with insulin in adipose tissue by using A1R knock out (-/-) mice. Removal of endogenous adenosine with adenosine deaminase caused lipolysis in A1R (+/+), but not A1R (-/-) adipocytes. The adenosine analogue, 2-chloroadenosine, inhibited noradrenaline-stimulated lipolysis and cAMP accumulation in A1R (+/+), but not in A1R (-/-) adipocytes. Insulin reduces lipolysis and cAMP via another mechanism than adenosine and acted additively, but not synergistically, with adenosine. Plasma levels of free fatty acids, glycerol and triglycerides were significantly lower in A1R (+/+) than in A1R (-/-) mice after administration of an adenosine analogue. 2-chloroadenosine induced lipogenesis in presence of insulin in A1R (+/+), but not in A1R (-/-) adipocytes. There were no changes in mRNA levels for several genes involved in fat synthesis in adipose tissue between genotypes. Body weight was similar in young A1R (+/+) and A1R (-/-) mice, but old male A1R (-/-) mice were heavier than wild type controls. In conclusion, adenosine inhibits lipolysis via the adenosine A1 receptor and other adenosine receptors play no significant role. Adenosine and insulin mediate additive but not synergistic antilipolytic effects and 2-chloroadenosine stimulates lipogenesis via adenosine A1 receptors. Thus deletion of adenosine A1 receptors should increase lipolysis and decrease lipogenesis, but in fact an increased fat mass was observed, indicating that other actions of adenosine A1 receptors, possibly outside adipose tissue, are also important.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789919     DOI: 10.1016/j.ejphar.2008.08.022

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  39 in total

1.  A2b adenosine receptor regulates hyperlipidemia and atherosclerosis.

Authors:  Milka Koupenova; Hillary Johnston-Cox; Alexander Vezeridis; Haralambos Gavras; Dan Yang; Vassilis Zannis; Katya Ravid
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.

Authors:  Ilia Korboukh; Emily A Hull-Ryde; Joseph E Rittiner; Amarjit S Randhawa; Jennifer Coleman; Brendan J Fitzpatrick; Vincent Setola; William P Janzen; Stephen V Frye; Mark J Zylka; Jian Jin
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

3.  Abrogation of adenosine A1 receptor signalling improves metabolic regulation in mice by modulating oxidative stress and inflammatory responses.

Authors:  Ting Yang; Xiang Gao; Monica Sandberg; Christa Zollbrecht; Xing-Mei Zhang; Michael Hezel; Ming Liu; Maria Peleli; En-Yin Lai; Robert A Harris; A Erik G Persson; Bertil B Fredholm; Leif Jansson; Mattias Carlström
Journal:  Diabetologia       Date:  2015-04-03       Impact factor: 10.122

Review 4.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

Review 5.  Neural innervation of white adipose tissue and the control of lipolysis.

Authors:  Timothy J Bartness; Yang Liu; Yogendra B Shrestha; Vitaly Ryu
Journal:  Front Neuroendocrinol       Date:  2014-04-13       Impact factor: 8.606

6.  Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors.

Authors:  Thorsten Gnad; Saskia Scheibler; Ivar von Kügelgen; Camilla Scheele; Ana Kilić; Anja Glöde; Linda S Hoffmann; Laia Reverte-Salisa; Philipp Horn; Samet Mutlu; Ali El-Tayeb; Mathias Kranz; Winnie Deuther-Conrad; Peter Brust; Martin E Lidell; Matthias J Betz; Sven Enerbäck; Jürgen Schrader; Gennady G Yegutkin; Christa E Müller; Alexander Pfeifer
Journal:  Nature       Date:  2014-10-15       Impact factor: 49.962

7.  CD73 Promotes Age-Dependent Accretion of Atherosclerosis.

Authors:  Nadia R Sutton; Diane Bouïs; Kris M Mann; Imran M Rashid; Alexandra L McCubbrey; Matt C Hyman; Daniel R Goldstein; Annie Mei; David J Pinsky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-17       Impact factor: 8.311

8.  Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice.

Authors:  Min He; Haoran Su; Weiwei Gao; Stina M Johansson; Qing Liu; Xiaoyan Wu; Jiayu Liao; Andrew A Young; Tamas Bartfai; Ming-Wei Wang
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

9.  Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.

Authors:  Martin Weiszenstein; Larissa A Shimoda; Michal Koc; Ondrej Seda; Jan Polak
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

Review 10.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.